Zinc Immune Meta-analysis: What the Evidence Says

Quick Answer

Zinc Immune Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Zinc deficiency has been associated with impaired immune responses, increased oxidative stress, compromised intestinal barrier function, and delayed wound healing-all of which are particularly relevant in the pathophysiology and management of IBD. [Muacevic Alexander (2026); evidence level 1]
• Multiple mechanisms contribute to zinc deficiency in IBD patients, including reduced dietary intake due to food aversions and restrictive diets, malabsorption secondary to intestinal inflammation and mucosal damage, increased gastrointestinal losses through diarrhea and protein-losing enteropathy, and drug-nutrient interactions with medications such as sulfasalazine and corticosteroids. [Muacevic Alexander (2026); evidence level 1]
• During pregnancy, zinc supplementation is frequently recommended to enhance maternal immunity, reduce the risk of infections, and support overall gestational health. [Mugundan Uma Maheshwari (2026); evidence level 3]
• However, direct clinical evidence remains limited, with only a small number of studies in pregnant women demonstrating an inverse relationship between zinc supplementation and copper status and no large-scale epidemiological data linking this interaction to neonatal outcomes. [Mugundan Uma Maheshwari (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For zinc immune meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Muacevic Alexander (2026). Zinc Deficiency Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. DOI: 10.7759/cureus.102684. PMCID: PMC12951249. PMID: 41777986. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12951249/
• Mugundan Uma Maheshwari (2026). Could excessive zinc supplementation during pregnancy cause menkes disease? A hypothesis worth investigating. DOI: 10.3389/fped.2026.1734361. PMCID: PMC13111262. PMID: 42051949. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13111262/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.